113 related articles for article (PubMed ID: 1874456)
21. Glutathione and N-acetylcysteine conjugates of 2-chloroethyl isocyanate. Identification as metabolites of N,N'-bis(2-chloroethyl)-N-nitrosourea in the rat and inhibitory properties toward glutathione reductase in vitro.
Davis MR; Kassahun K; Jochheim CM; Brandt KM; Baillie TA
Chem Res Toxicol; 1993; 6(3):376-83. PubMed ID: 8318660
[TBL] [Abstract][Full Text] [Related]
22. The effects of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue.
Maker HS; Weiss C; Brannan TS
Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):355-66. PubMed ID: 6622814
[TBL] [Abstract][Full Text] [Related]
23. Reduction of glutathione levels in livers of mice treated with N,N'-bis (2-chloroethyl)-N-nitrosourea.
McConnell WR; Kari P; Hill DL
Cancer Chemother Pharmacol; 1979; 2(3):221-3. PubMed ID: 455578
[TBL] [Abstract][Full Text] [Related]
24. Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes.
Babson JR; Abell NS; Reed DJ
Biochem Pharmacol; 1981 Aug; 30(16):2299-304. PubMed ID: 7295342
[No Abstract] [Full Text] [Related]
25. Cell killing by various nitrosoureas and the potentiating effect of caffeine.
Goth-Goldstein R
Mutat Res; 1982 Jun; 94(2):237-44. PubMed ID: 7110175
[TBL] [Abstract][Full Text] [Related]
26. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
[TBL] [Abstract][Full Text] [Related]
27. Effect of inhibition of glutathione reductase by carmustine on central nervous system oxygen toxicity.
Powell SR; Puglia CD
J Pharmacol Exp Ther; 1987 Jan; 240(1):111-7. PubMed ID: 3806383
[TBL] [Abstract][Full Text] [Related]
28. Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.
Berger MR; Henne T; Bedford P
J Cancer Res Clin Oncol; 1985; 110(3):185-90. PubMed ID: 4077917
[TBL] [Abstract][Full Text] [Related]
29. Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.
Helal GK; Helal OK
Arch Toxicol; 2009 Jan; 83(1):87-94. PubMed ID: 18528683
[TBL] [Abstract][Full Text] [Related]
30. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells.
Smith MT; Evans CG; Doane-Setzer P; Castro VM; Tahir MK; Mannervik B
Cancer Res; 1989 May; 49(10):2621-5. PubMed ID: 2713846
[TBL] [Abstract][Full Text] [Related]
31. Comparison of DNA lesions produced by tumor-inhibitory 1,2-bis(sulfonyl)hydrazines and chloroethylnitrosoureas.
Penketh PG; Shyam K; Sartorelli AC
Biochem Pharmacol; 2000 Feb; 59(3):283-91. PubMed ID: 10609557
[TBL] [Abstract][Full Text] [Related]
32. Decreased DNA interstrand cross-linking and cytotoxicity induced in human brain tumor cells by 1,3-bis(2-chloroethyl)-1-nitrosourea after in vitro reaction with glutathione.
Ali-Osman F; Caughlan J; Gray GS
Cancer Res; 1989 Nov; 49(21):5954-8. PubMed ID: 2551496
[TBL] [Abstract][Full Text] [Related]
33. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
Weber GF; Waxman DJ
Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of inhibition of red blood cell glutathione reductase activity by BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea).
Shinohara K; Tanaka KR
Clin Chim Acta; 1979 Mar; 92(2):147-52. PubMed ID: 39688
[TBL] [Abstract][Full Text] [Related]
35. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
Bedford P; Berger MR; Eisenbrand G; Schmähl D
J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
[TBL] [Abstract][Full Text] [Related]
36. Glutathione reductase-deficient erythrocytes as host cells of malarial parasites.
Zhang Y; König I; Schirmer RH
Biochem Pharmacol; 1988 Mar; 37(5):861-5. PubMed ID: 3278713
[TBL] [Abstract][Full Text] [Related]
37. Role of glutathione reductase during menadione-induced NADPH oxidation in isolated rat hepatocytes.
Smith PF; Alberts DW; Rush GF
Biochem Pharmacol; 1987 Nov; 36(22):3879-84. PubMed ID: 3689427
[TBL] [Abstract][Full Text] [Related]
38. Effect of BCNU pretreatment on diquat-induced oxidant stress and hepatotoxicity.
Smith CV
Biochem Biophys Res Commun; 1987 Apr; 144(1):415-21. PubMed ID: 3579917
[TBL] [Abstract][Full Text] [Related]
39. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
Rice KP; Penketh PG; Shyam K; Sartorelli AC
Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
[TBL] [Abstract][Full Text] [Related]
40. Oxidation of glutathione during hydroperoxide metabolism. A study using isolated hepatocytes and the glutathione reductase inhibitor 1,3-bis(2-chloroethyl)-1-nitrosourea.
Eklöw L; Moldéus P; Orrenius S
Eur J Biochem; 1984 Feb; 138(3):459-63. PubMed ID: 6692829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
